Literature DB >> 14607793

Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.

M Tazir1, H Azzedine, S Assami, P Sindou, S Nouioua, R Zemmouri, T Hamadouche, M Chaouch, J Feingold, J M Vallat, E Leguern, D Grid.   

Abstract

Autosomal recessive forms of axonal Charcot-Marie-Tooth (ARCMT2) disease are frequent in some areas, such as North Africa and the Middle East, since consanguineous marriages are still common there. Recently, a unique homozygous mutation in LMNA, which encodes lamin A/C, a component of the nuclear envelope, was identified in members of three Algerian families with ARCMT2 linked to chromosome 1q21.2-q21.3. In the present study we describe a group of 21 ARCMT2 patients from seven unrelated Algerian families with the same R298C mutation in the lamin A/C gene and marked variability of the clinical phenotype. There is a wide range of age of onset, from 6 to 27 years, with a mean of 14.4 +/- 4.6 years. The course of the disease varies considerably from one patient to another. Twelve patients with a disease duration of 10-15 years had a severe CMT phenotype with distal wasting and weakness of all four limbs and areflexia associated with involvement of the proximal lower limb muscles. In contrast, nine patients had the classical CMT phenotype with mild functional disability without proximal lower limb involvement after a disease duration of 5-18 years. Electrophysiological studies showed a median motor nerve conduction velocity (MNCV) in the normal range in almost all the patients. MNCV and compound muscle action potential (CMAP) values were inversely correlated with the disease duration and the MNCV was strictly related to the CMAP, strongly supporting a pure axonal process without a demyelinating component. Six patients had a nerve biopsy, which revealed severe rarefaction of myelinated fibres in all cases and an increased density of unmyelinated fibres in the majority of cases. In conclusion, the ARCMT2 associated with the R298C mutation differs from other types of ARCMT2. The variability among patients in the age of onset and the course of the disease strongly suggests the action of modifying genes, which remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607793     DOI: 10.1093/brain/awh021

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  18 in total

Review 1.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 2.  Nuclear mechanics in disease.

Authors:  Monika Zwerger; Chin Yee Ho; Jan Lammerding
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

Review 3.  Diseases of the nuclear envelope.

Authors:  Howard J Worman; Cecilia Ostlund; Yuexia Wang
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 4.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 5.  The nuclear envelope: an intriguing focal point for neurogenetic disease.

Authors:  Howard J Worman; William T Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 6.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 7.  Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies.

Authors:  Rafaëlle Bernard; Annachiara De Sandre-Giovannoli; Valérie Delague; Nicolas Lévy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 8.  Beyond membrane channelopathies: alternative mechanisms underlying complex human disease.

Authors:  Konstantinos Dean Boudoulas; Peter J Mohler
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 9.  Recent advances in the genetics of hereditary axonal sensory-motor neuropathies type 2.

Authors:  Senda Ajroud-Driss; Han-Xiang Deng; Teepu Siddique
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

10.  Autosomal recessive forms of Charcot-Marie-Tooth disease.

Authors:  J M Vallat; D Grid; C Magdelaine; F Sturtz; M Tazir
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.